Stability of Cervical Specimens in SurePath Medium for HPV Testing
نویسندگان
چکیده
7 8 Laura Gilbert, Elizabeth Oates, Samuel Ratnam 9 10 11 Newfoundland and Labrador Public Health Laboratory, St. John’s, 12 Newfoundland and Labrador, Canada; 13 Memorial University, St. John's, Newfoundland and Labrador, Canada; National Microbiology Laboratory, 14 Public Health Agency of Canada, Winnipeg, Manitoba, Canada 15 16 ______________________________________________________________________ 17 *Corresponding author: Newfoundland and Labrador Public Health Laboratory, Dr. L.A. Miller Centre, 18 Suite 1, 100 Forest Road, St. John’s, NL. Canada. A1A 3Z9. Phone: 709 777 7230. Fax: 709 777 7070. 19 E-mail: [email protected] 20 Copyright © 2013, American Society for Microbiology. All Rights Reserved. J. Clin. Microbiol. doi:10.1128/JCM.01391-13 JCM Accepts, published online ahead of print on 31 July 2013
منابع مشابه
Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.
The stability of cervical specimens in SurePath preservative fluid for human papillomavirus (HPV) testing with Roche cobas 4800 was determined using a panel of 308 pooled specimens from a colposcopy referral population. The SurePath specimens appeared to be stable for up to 10 weeks at ambient temperature for HPV testing with cobas 4800.
متن کاملCervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests
None of the commercial HPV tests are U.S. FDA-approved for testing of cervical cytology specimens in SurePath preservative. Still, ~30% of HPV testing is performed on specimens in this formalin-containing preservative. Formalin-induced DNA fragmentation and cross-linking may interfere with HPV detection. We evaluated analytical sensitivity and specimen stability of the cobas 4800 HPV (Roche) an...
متن کاملLimitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
OBJECTIVE To increase awareness of the limitations of high-risk human papillomavirus (hrHPV) laboratory-developed testing (LDT) widely used in US cervical cancer screening. METHODS AND RESULTS A young woman in her 30s was diagnosed and treated for stage 1B1 cervical squamous cell carcinoma in which HPV 16 DNA was detected using polymerase chain reaction testing. Both 1 month before and 42 mon...
متن کاملComparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
BACKGROUND Liquid-based cytology (LBC) has been compared with conventional cytology in numerous studies. In the current study of 2 LBC systems, the accuracy, rates of unsatisfactory cytology, and sufficiency of residual LBC specimens for Hybrid Capture 2 (HC2) HPV DNA testing were compared. METHODS Eligible women ages 30 to 49 years were recruited for this cross-sectional population-based stu...
متن کاملCytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
BACKGROUND The objective of this study was to evaluate a newly-developed EASYPREP liquid-based cytology method in cervicovaginal specimens and compare it with SurePath. METHODS Cervicovaginal specimens were prospectively collected from 1,000 patients with EASYPREP and SurePath. The specimens were first collected by brushing for SurePath and second for EASYPREP. The specimens of both methods w...
متن کامل